Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "GE Healthcare's"


10 mentions found


In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Following AMD's better-than-feared Q2 release late Tuesday, we raised our price target on the stock to $135 per share from $120. Wednesday On this relatively calm day, we reiterated our 1 rating and $110 price target on shares of Emerson Electric (EMR). Against this bullish backdrop, we raised our price target on Amazon to $160 per share, up from $140. Our previous price target was $185.
Persons: Here's, Johnson, Stanley Black, Decker, Jim Cramer, AMD's, Emerson, , it's, Eli Lilly, LLY, Walt Disney, We'll, Jim Cramer's, Jim, Jim Cramer Rob Kim Organizations: Club, Microsoft, GE Healthcare, GE, Honeywell International, Caterpillar, Devices, Honeywell, Turnaround, AMD, Emerson Electric, National, Big Tech, Apple, Coterra Energy, Wynn Resorts, WYNN, Jim Cramer's Charitable, CNBC Locations: MSFT, GEHC, Missouri
We are buying 225 shares of GE Healthcare (GEHC), at roughly $76.84 each, and 45 shares of Microsoft (MSFT), at roughly $334.26 apiece. The first position we are adding to is GE Healthcare Technologies . GE Healthcare fared much better than Dutch peer Phillips, which last week said its orders fell 8% in the second quarter. The difference in the two order rates suggests GE Healthcare is gaining market share. The medical-technology firm is seeing good momentum in its business, partly because many health-care providers are investing to improve patient care and productivity.
Persons: Jim Cramer's, Johnson, Phillips, what's, We've, we've, Jim Cramer, Jim, Spencer Platt Organizations: GE Healthcare, Microsoft, GEHC, Johnson, GE Healthcare Technologies, GE, Electric, CNBC, Traders, New York Stock Exchange, Getty Locations: , New York City
July 25 (Reuters) - GE HealthCare Technologies Inc (GEHC.O) raised its annual profit forecast on Tuesday, after beating quarterly earnings estimates due to easing supply chain issues that had largely impacted electronic components during the pandemic. Johnson & Johnson (JNJ.N) and Abbott Laboratories (ABT.N), which make medical devices like heart stents and implants, surpassed quarterly profit estimates last week as patients underwent their delayed procedures. GE HealthCare on Tuesday reported total quarterly sales of $4.8 billion, in line with analysts' estimates. Of this, $2.6 billion came from sales of imaging devices such as magnetic resonance imaging (MRI) and $839 million from ultrasound devices. The healthcare equipment firm operates four medical device businesses - imaging and ultrasound devices, patient care solutions and pharmaceutical diagnostics - with imaging being the largest.
Persons: Johnson, Khushi, Shailesh Organizations: GE HealthCare Technologies Inc, GE, Johnson, Abbott Laboratories, GE HealthCare, General Electric, Thomson Locations: Bengaluru
We first bought up a modest number of GE Healthcare shares in May, while patiently waiting for a retreat in the price. The difference between the two companies suggests to us that GE Healthcare may be taking market share in the industry. General Electric (GE) spun off GE Healthcare at the start of this year. Guidance Off the strength of the first half of the year, GE Healthcare raised its full-year outlook for organic revenue growth and adjusted EPS. Alzheimer's opportunity We continue to see upside for GE Healthcare as it attracts new business to support the launch of nascent Alzheimer's therapies.
Persons: GEHC, It's, Phillips, EBIT, Peter Arduini, Jim Cramer, Jim Cramer's, Jim, Jakub Porzycki Organizations: GE Healthcare Technologies, Alzheimer's, GE Healthcare, Dutch, GE, General Electric, CNBC, Nurphoto, Getty Locations: U.S
Cramer's Lightning Round: GE Healthcare is a buy
  + stars: | 2023-06-14 | by ( Julie Coleman | ) www.cnbc.com   time to read: +2 min
Stock Chart Icon Stock chart icon GE Healthcare's year-to-date stock performance. Stock Chart Icon Stock chart icon NGL Energy's year-to-date stock performance. Stock Chart Icon Stock chart icon Fuelcell Energy's year-to-date stock performance. Stock Chart Icon Stock chart icon Pampa Energia SA's year-to-date stock performance. Stock Chart Icon Stock chart icon Annaly Capital's year-to-date stock performance.
Persons: we've, NGL, Fuelcell, it's, Argentina's, Brazil's, Enphase, Annaly, Jim Cramer's Organizations: GE, GE Healthcare, CNBC, NGL, Fuelcell, Pampa Energia, Pampa Energia SA, Enphase, Annaly Locations: Pampa, it's
GE Healthcare (GEHC) shares are sliding Thursday, giving Club members an opportunity to invest in the medical-technology company at an increasingly attractive valuation. The noise around this transaction seems to be dragging down GE Healthcare shares. Thursday's declines push GE Healthcare shares below our cost basis of $79.47, which typically is a welcome development for a newer, smaller position. Essentially, what's happening now is General Electric is exchanging more than a quarter of its GEHC shares in a deal with Morgan Stanley. So, it's hardly a surprise to see General Electric monetizing some of its GE Healthcare stake to improve its balance sheet.
Persons: Jim Cramer, we're, we'd, Jim, Electric's, isn't, Morgan Stanley, Larry Culp, Global's, dilutive, Jim Cramer's, Yi Haifei Organizations: GE Healthcare, Electric, GE, CNBC, General Electric, GE Vernova, Intel, Mobileeye, Fair for Trade, Services, China National Convention Center, China News Service, Getty Locations: China, Beijing
We're initiating a position in GE Healthcare (GEHC), buying 325 shares at roughly $79 each. GE Healthcare is the global leader in medical imaging, diagnostics, and digital solutions. GE Healthcare is one of the global leaders in Precision Diagnostics with an industry-leading injectable pharmaceutical portfolio in contrast media and molecular imaging. GE Healthcare is one of a few companies that offer a full suite of products and solutions to support patients. GEHC YTD mountain GE Healthcare YTD performance Analysts see GE Healthcare growing EPS to $4.33 in 2024, about a 15% increase from this year's outlook.
In a research note published last week, Kostin updated that study to look at the track records of more recent spinoffs, completed over the past two years. "However, while 11 of the 20 spinoffs completed during 2022 outperformed the S & P 500 since transaction completion, only six of the spinoffs outperformed their parent entities." The largest completed deal in 2022 was General Electric' s spin off of GE HealthCare , a $26 billion business. The next largest completed deal last year was Intel's spinoff of Mobileye , which wrapped up on Oct. 26, 2022 . In 2021, the value of the completed spinoffs hit $112 billion, and included Dell's spinoff of VMWare , the largest deal at $57 billion.
Tesla — Shares dropped 2.8% after Berenberg lowered its earnings estimate for Tesla by around 25% for 2023 following the company's price cuts for its electric vehicles. Ford Motor Company — Shares fell nearly 1.4% after the company announced price cuts for its electric Mustang Mach-E crossover. The move in Ford comes after Tesla said earlier this month it would trim prices to counteract dwindling demand. AMC Entertainment — Common shares of the theater chain fell by more than 7% after AMC announced a shareholder meeting in March for a potential change to its capital structure. The preferred or "APE" shares, which trade at a large discount to the common shares, jumped by more than 16%.
read moreSome of the largest U.S. hospitals said on Tuesday they are facing critical shortages of iodinated contrast media products. The Greater New York Hospital Association (GNYHA) warned on May 4 of temporary supply shortages of GE Healthcare's iodinated contrast media - specifically its Omnipaque products made in Shanghai. "We are working around the clock to expand capacity of our iodinated contrast media products," a GE spokesperson said after the company had to close its Shanghai facility for several weeks due to local COVID policies. GE Healthcare has four contrast media manufacturing facilities, including the one in Shanghai. A spokesperson for Bayer (BAYGn.DE), which competes with GE Healthcare in contrast media, said it is not facing a similar situation.
Total: 10